Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed May 10, 2022 · 10-Q · 40 days after period end · 0001280776-22-000012
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$20.81M | -$34.53M | -$8.49M | -$4.31M |
| EPS Diluted | -$0.74 | -$1.63 | -$0.79 | -$5.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 10, 2022 · 40 d after period end
